-
1Academic Journal
Authors: D. A. Sokolov, I. A. Kozlov, Д. А. Соколов, И. А. Козлов
Source: Messenger of ANESTHESIOLOGY AND RESUSCITATION; Том 22, № 1 (2025); 6-15 ; Вестник анестезиологии и реаниматологии; Том 22, № 1 (2025); 6-15 ; 2541-8653 ; 2078-5658
Subject Terms: фосфокреатин, non-cardiac surgery, vascular surgery, perioperative cardioprotection, dexmedetomidine, phosphocreatin, некардиальная хирургия, операции на сосудах, периоперационная кардиопротекция, дексмедетомидин
File Description: application/pdf
Relation: https://www.vair-journal.com/jour/article/view/1151/772; Заболотских И. Б., Потиевская В. И., Баутин А. Е. и др. Периоперационное ведение пациентов с ишемической болезнью сердца // Анестезиология и реаниматология. – 2020. – № 3. – С. 5–16. https://doi.org/10.17116/anaesthesiology20200315.; Козлов И. А., Соколов Д. А., Любошевский П. А. Эффективность дексмедетомидиновой кардиопротекции при операциях на сосудах у больных высокого кардиального риска // Вестник анестезиологии и реаниматологии. – 2024. – Т. 21, № 2. – С. 6–17. https://doi.org/10.24884/2078-5658-2024-21-2-6-17.; Козлов И. А., Соколов Д. А., Любошевский П. А. Эффективность фосфокреатиновой кардиопротекции при операциях на сосудах у больных высокого кардиального риска // Вестник анестезиологии и реаниматологии. – 2024. Т. 21, № 3. – С. 6–16. https://doi.org/10.24884/2078-5658-2024-21-3-6-16.; Мурашко С. С., Бернс С. А., Пасечник И. Н. Сердечно-сосудистые осложнения в некардиальной хирургии: что остается вне поля зрения? // Кардиоваскулярная терапия и профилактика. – 2024. – Т. 23, № 1. – С. 3748. https://doi.org/10.15829/1728-8800-2024-3748.; Соколов Д. А., Каграманян М. А., Козлов И. А. Расчетные гематологические индексы как предикторы сердечно-сосудистых осложнений в некардиальной хирургии (пилотное исследование) // Вестник анестезиологии и реаниматологии. – 2022. – Т. 19, № 2. – С. 14–22. https://doi.org/10.21292/2078-5658-2022-19-2-14-22.; Соколов Д. А., Любошевский П. А., Староверов И. Н., Козлов И. А. Постгоспитальные сердечно-сосудистые осложнения у больных, перенесших некардиохирургические операции // Вестник анестезиологии и реаниматологии. –2021. – Т. 18, № 4. – С. 62–72. https://doi.org/10.21292/2078-5658-2021-18-4-62-72.; Сумин А. Н., Дупляков Д. В., Белялов Ф. И. и др. Рекомендации по оценке и коррекции сердечнососудистых рисков при несердечных операциях. Российское кардиологическое общество // Российский кардиологический журнал. – 2023. – Т. 28, № 8. – С. 5555. https://doi.org/10.15829/1560-4071-20235555.; Чаулин А. М., Григорьева Ю. В., Павлова Т. В. и др. Диагностическая ценность клинического анализа крови при сердечно-сосудистых заболеваниях // Российский кардиологический журнал. – 2020. – Т. 25, № 12. – С. 172–177. https://doi.org/10.15829/1560-4071-2020-3923.; Ackland G. L., Abbott T. E. F., Cain D. et al. Preoperative systemic inflammationand perioperative myocardial injury. – P. prospective observational multicentre cohort study of patients undergoing non-cardiac surgery // British J. Anaesth. – 2019. – Vol. 122, № 2. – P. 180–187. https://doi.org/10.1016/j.bja.2018.09.002.; Álvarez-Garcia J., Popova E., Vives-Borrás M. et al. Myocardial injury after major non-cardiac surgery evaluated with advanced cardiac imaging: a pilot study // BMC Cardiovasc Disord. – 2023. – Vol. 23, № 1. – P. 78. https://doi.org/10.1186/s12872-023-03065-6.; Beaulieu R. J., Sutzko D. C., Albright J. et al. Association of high mortality with postoperative myocardial infarction after major vascular surgery despite use of evidence-based therapies // JAMA Surg. – 2020. – Vol. 155, № 2. – P. 131–137. https://doi.org/10.1001/jamasurg.2019.4908.; Bhutta H., Agha R., Wong J. et al. Neutrophil-lymphocyte ratio predicts medium-term survival following elective major vascular surgery: a cross-sectional study // Vasc. Endovasc. Surg. – 2011. – Vol. 45, № 3. – P. 227–231. https://doi.org/10.1177/1538574410396590.; Bignami E., Greco T., Barile L. et al. The effect of isoflurane on survival and myocardial infarction: a meta-analysis of randomized controlled studies // J Cardiothorac Vasc Anesth. – 2013. – Vol. 27, № 1. – P. 50-58. https://doi.org/10.1053/j.jvca.2012.06.007.; Blessberger H., Lewis S. R., Pritchard M. W. et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing non-cardiac surgery // Cochrane Database Syst Rev. – 2019. – Vol. 9, № 9. – P. CD013438. https://doi.org/10.1002/14651858.CD013438.; Borger M., von Haefen C., Bührer C. et al. Cardioprotective effects of dexmedetomidine in an oxidative-stress in vitro model of neonatal rat cardiomyocytes // Antioxidants (Basel). – 2023. – Vol. 12, № 6. – P. 1206. https://doi.org/10.3390/antiox12061206.; Choi B., Oh A. R., Park J. et al. Perioperative adverse cardiac events and mortality after non-cardiac surgery: a multicenter study // Korean J Anesthesiol. – 2024. – Vol. 77, № 1. – P. 66–76. https://doi.org/10.4097/kja.23043.; Devereaux P. J., Duceppe E., Guyatt G. et al. MANAGE Investigators. Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial // Lancet. – 2018. – Vol. 391, № 10137. – P. 2325–2334. https://doi.org/10.1016/S0140-6736(18)30832-8.; Devereaux P. J., Goldman L., Cook D. J. et al. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk // CMAJ. – 2005. – Vol. 173, № 6. – P. 627–634. https://doi.org/10.1503/cmaj.050011.; Durmus G., Belen E., Can M. M. Increased neutrophil to lymphocyte ratio predicts myocardial injury in patients undergoing non-cardiac surgery // Heart Lung. – 2018. – Vol. 47, № 3. – P. 243–247. https://doi.org/10.1016/j.hrtlng.2018.01.005.; Gillis C., Ljungqvist O., Carli F. Prehabilitation, enhanced recovery after surgery, or both? A narrative review // Br J Anaesth. – 2022. – Vol. 128, № 3. – P. 434–448. https://doi.org/10.1016/j.bja.2021.12.007.; Green S. B. How many subjects does it take to do a regression analysis // Multivariate Behav Res. – 1991. – Vol. 26, № 3. – P. 499–510. https://doi.org/10.1207/s15327906mbr2603_7.; Halvorsen S., Mehilli J., Cassese S. et al. ESC Scientific Document GrouP. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery // Eur Heart J. – 2022. – Vol. 43, № 39. – P. 3826–3924. https://doi.org/10.1093/eurheartj/ehac270.; Handke J., Scholz A. S., Gillmann H. J. et al. elevated presepsin is associated with perioperative major adverse cardiovascular and cerebrovascular complications in elevated-risk patients undergoing noncardiac surgery: the leukocytes and cardiovascular perioperative events study // Anesth Analg. – 2019. – Vol. 128, № 6. – P. 1344–1353. https://doi.org/10.1213/ANE.0000000000003738.; Imtiaz F., Shafique K., Mirza S. S. et al. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population // Int. Arch. Med. – 2012. – Vol. 5, № 1. – P. 2. https://doi.org/10.1186/1755-7682-5-2.; Kampman J. M., Hermanides J., Hollmann M. W. et al. Mortality and morbidity after total intravenous anaesthesia versus inhalational anaesthesia: a systematic review and meta-analysis // EClinicalMedicine. – 2024. – Vol. 72. – P. 102636. https://doi.org/10.1016/j.eclinm.2024.102636.; Khan A., Johnson D. K., Carlson S. et al. NT-Pro BNP predicts myocardial injury post-vascular surgery and is reduced with CoQ10: a randomized double-blind trial // Ann Vasc Surg. – 2020. – Vol. 64. – P. 292–302. https://doi.org/10.1016/j.avsg.2019.09.017.; Larmann J., Handke J., Scholz A. S. et al. Preoperative neutrophil to lymphocyte ratio and latelet to lymphocyte ratio are associated with major adverse cardiovascular and cerebrovascular events in coronary heart disease patients undergoing non-cardiac surgery // BMC Cardiovascular Disorders. – 2020. – Vol. 20. – P. 230–239. https://doi.org/10.1186/s12872-020-01500-6.; Lawrence C. J., Prinzen F. W., de Lange S. The effect of dexmedetomidine on the balance of myocardial energy requirement and oxygen supply and demand // Anesth Analg. – 1996. – Vol. 82, № 3. – P. 544–550. https://doi.org/10.1097/00000539-199603000-00021.; Ling M. Y., Song Y. P., Liu C. et al. Protection of exogenous phosphocreatine for myocardium in percutaneous coronary intervention related to inflammation // Rev Cardiovasc Med. – 2022. – Vol. 23, № 3. – P. 89. https://doi.org/10.31083/j.rcm2303089.; Lionetti V., Barile L. Perioperative cardioprotection: back to bedside. Minerva Anestesiol. – 2020. – Vol. 86, № 4. – P. 445–454. https://doi.org/10.23736/S0375-9393.19.13848-5.; Mangano D. T., Browner W. S., Hollenberg M. et al. Long-term cardiac prognosis following noncardiac surgery. The Study of Perioperative Ischemia Research Group // JAMA. – 1992. – Vol. 268, № 2. – P. 233–239. https://doi.org/10.1001/jama.268.2.233.; Mastroroberto P., Chello M., Zofrea S. et al. Cardioprotective Effects of Phosphocreatine in Vascular Surgery // Vasc Endovasc Surgery. – 1995. – Vol. 29, № 4. – P. 255–260. https://doi.org/10.1177/153857449502900401.; Oh A. R., Park J., Lee J. H. et al. Association between perioperative adverse cardiac events and mortality during one-year follow-up after noncardiac surgery // J Am Heart Assoc. – 2022. – Vol. 11, № 8. – P. e024325. https://doi.org/10.1161/JAHA.121.024325.; Paulus W. J., Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation // J Am Coll Cardiol. – 2013. – Vol. 62, № 4. – P. 263–71. https://doi.org/10.1016/j.jacc.2013.02.092.; Puelacher C., Gualandro D. M., Glarner N. et al. BASEL-PMI Investigators. Long-term outcomes of perioperative myocardial infarction/injury after non-cardiac surgery // Eur Heart J. – 2023. – Vol. 44, № 19. – P. 1690–1701. https://doi.org/10.1093/eurheartj/ehac798.; Sazgary L., Puelacher C., Lurati Buse G. et al. BASEL-PMI Investigators. Incidence of major adverse cardiac events following non-cardiac surgery // Eur Heart J Acute Cardiovasc Care. – 2021. – Vol. 10, № 5. – P. 550–558. https://doi.org/10.1093/ehjacc/zuaa008.; Shannon A. H., Mehaffey J. H., Cullen J. M. et al. Preoperative beta blockade is associated with increased rates of 30-day major adverse cardiac events in critical limb ischemia patients undergoing infrainguinal revascularization // J Vasc Surg. – 2019. – Vol. 69, № 4. – P. 1167–1172.e1. https://doi.org/10.1016/j.jvs.2018.07.077.; Smilowitz N. R., Redel-Traub G., Hausvater A. et al. Myocardial Injury After Noncardiac Surgery: A Systematic Review and Meta-Analysis // Cardiol Rev. – 2019. – Vol. 27, № 6. – P. 267–273. https://doi.org/10.1097/CRD.0000000000000254.; Soliman R., Zohry G. The myocardial protective effect of dexmedetomidine in high-risk patients undergoing aortic vascular surgery // Ann Card Anaesth. – 2016. – Vol. 19, № 4. – P. 606–613. https://doi.org/10.4103/0971-9784.191570.; Strickland S. S., Quintela E. M., Wilson M. J., Lee M. J. Long-term major adverse cardiovascular events following myocardial injury after non-cardiac surgery: meta-analysis // BJS Open. – 2023. – Vol. 7, № 2. – P. zrad021. https://doi.org/10.1093/bjsopen/zrad021.; Strumia E., Pelliccia F., D’Ambrosio G. Creatine phosphate: pharmacological and clinical perspectives // Adv Ther. – 2012. – Vol. 29, № 2. – P. 99–123. https://doi.org/10.1007/s12325-011-0091-4.; Sultan P., Edwards M. R., Gutierrez del Arroyo A. et al. Cardiopulmonary exercise capacity and preoperative markers of inflammation // Mediators Inflamm. – 2014. – Vol. 2014. – P. 727451. https://doi.org/10.1155/2014/727451.; Torregroza C., Raupach A., Feige K. et al. Perioperative cardioprotection: general mechanisms and pharmacological approaches // Anesth Analg. – 2020. – Vol. 131, № 6. – P. 1765–1780. https://doi.org/10.1213/ANE.0000000000005243.; Wang K., Wu M., Xu J. et al. Effects of dexmedetomidine on perioperative stress, inflammation, and immune function: systematic review and meta-analysis // Br J Anaesth. – 2019. – Vol. 123, № 6. – P. 777–794. https://doi.org/10.1016/j.bja.2019.07.027.; Yan P., Chen S. Q., Li Z. P. et al. Effect of exogenous phosphocreatine on cardiomycytic apoptosisand expression of Bcl-2 and Bax after cardiopulmonary resuscitation in rats // World J. Emerg. Med. – 2011. – Vol. 2, № 4. – P. 291–295. https://doi.org/10.5847/wjem.j.1920-8642.2011.04.009.; Yang Y. F., Wang H., Song N. et al. Dexmedetomidine attenuates ischemia/reperfusion-induced myocardial inflammation and apoptosis through inhibiting endoplasmic reticulum stress signaling // J Inflamm Res. – 2021. – Vol. 14. – P. 1217–1233. https://doi.org/10.2147/jir.S292263.; Zhang W., Zhang H., Xing Y. Protective effects of phosphocreatine administered post-treatment combined with ischemic post-conditioning on rat hearts with myocardial ischemia/reperfusion injury // J. Clin. Med. Res. – 2015. – Vol. 7, № 4. – P. 242–247. https://doi.org/10.14740/jocmr2087w.